AAAAAA

   
Results: 1-15 |
Results: 15
THE PHARMACODYNAMICS AND PHARMACOKINETICS OF THE 5HT(1B 1D)-AGONIST ZOLMITRIPTAN IN HEALTHY-YOUNG AND ELDERLY MEN AND WOMEN/
Authors: PECK RW SEABER EJ DIXON RM LAYTON GR WEATHERLEY BC JACKSON SHD ROLAN PE POSNER J
Citation: Rw. Peck et al., THE PHARMACODYNAMICS AND PHARMACOKINETICS OF THE 5HT(1B 1D)-AGONIST ZOLMITRIPTAN IN HEALTHY-YOUNG AND ELDERLY MEN AND WOMEN/, Clinical pharmacology and therapeutics, 63(3), 1998, pp. 342-353
PERIPHERAL VASCULAR EFFECTS AND PHARMACOKINETICS OF THE ANTIMIGRAINE COMPOUND, ZOLMITRIPTAN, IN COMBINATION WITH ORAL ERGOTAMINE IN HEALTHY-VOLUNTEERS
Authors: DIXON RM MEIRE HB EVANS DH WATT H ON N POSNER J ROLAN PE
Citation: Rm. Dixon et al., PERIPHERAL VASCULAR EFFECTS AND PHARMACOKINETICS OF THE ANTIMIGRAINE COMPOUND, ZOLMITRIPTAN, IN COMBINATION WITH ORAL ERGOTAMINE IN HEALTHY-VOLUNTEERS, Cephalalgia, 17(6), 1997, pp. 639-646
INVESTIGATION OF MULTIPLE-DOSE CITALOPRAM ON THE PHARMACOKINETICS ANDPHARMACODYNAMICS OF RACEMIC WARFARIN
Authors: PRISKORN M SIDHU JS LARSEN F DAVIS JD KHAN AZ ROLAN PE
Citation: M. Priskorn et al., INVESTIGATION OF MULTIPLE-DOSE CITALOPRAM ON THE PHARMACOKINETICS ANDPHARMACODYNAMICS OF RACEMIC WARFARIN, British journal of clinical pharmacology, 44(2), 1997, pp. 199-202
THE ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (311C90)
Authors: SEABER E ON N DIXON RM GIBBENS M LEAVENS WJ LIPTROT J CHITTICK G POSNER J ROLAN PE PECK RW
Citation: E. Seaber et al., THE ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (311C90), British journal of clinical pharmacology, 43(6), 1997, pp. 579-587
COMPARISON OF THE PHARMACOKINETICS OF LAMOTRIGINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE AND HEALTHY-VOLUNTEERS
Authors: WOOTTON R SOULLAWTON J ROLAN PE SHEUNG CTCF COOPER JDH POSNER J
Citation: R. Wootton et al., COMPARISON OF THE PHARMACOKINETICS OF LAMOTRIGINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE AND HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 43(1), 1997, pp. 23-27
DISPOSITION OF ATOVAQUONE IN HUMANS
Authors: ROLAN PE MERCER AJ TATE E BENJAMIN I POSNER J
Citation: Pe. Rolan et al., DISPOSITION OF ATOVAQUONE IN HUMANS, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1319-1321
PHARMACOKINETICS OF VALSARTAN IN PATIENTS WITH LIVER-DISEASE
Authors: BROOKMAN LJ ROLAN PE BENJAMIN IS PALMER KR WYLD PJ LLOYD P FLESCH G WALDMEIER F SIOUFI A MULLINS F
Citation: Lj. Brookman et al., PHARMACOKINETICS OF VALSARTAN IN PATIENTS WITH LIVER-DISEASE, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 272-278
EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DESIRUDIN
Authors: LEFEVRE G DUVAL M GAURON S BROOKMAN LJ ROLAN PE MORRIS TM PIRAINO AJ MORGAN JM PALMISANO M CLOSE P
Citation: G. Lefevre et al., EFFECT OF RENAL IMPAIRMENT ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DESIRUDIN, Clinical pharmacology and therapeutics, 62(1), 1997, pp. 50-59
EVALUATION OF NONINVASIVE TECHNIQUES TO ASSESS VASOCONSTRICTION IN HEALTHY-VOLUNTEERS USING METHOXAMINE AS A PROBE DRUG
Authors: DIXON RM MEIRE HB LEIGH C POSNER J ROLAN PE
Citation: Rm. Dixon et al., EVALUATION OF NONINVASIVE TECHNIQUES TO ASSESS VASOCONSTRICTION IN HEALTHY-VOLUNTEERS USING METHOXAMINE AS A PROBE DRUG, Cephalalgia, 16(7), 1996, pp. 507-517
THE UTILITY OF THE COLD PAIN TEST TO MEASURE ANALGESIA FROM INTRAVENOUS MORPHINE
Authors: VAN F ROLAN PE
Citation: F. Van et Pe. Rolan, THE UTILITY OF THE COLD PAIN TEST TO MEASURE ANALGESIA FROM INTRAVENOUS MORPHINE, British journal of clinical pharmacology, 42(5), 1996, pp. 663-664
ATOVAQUONE HAS NO EFFECT ON THE PHARMACOKINETICS OF PHENYTOIN IN HEALTHY MALE-VOLUNTEERS
Authors: DAVIS JD DIXON R KHAN AZ TOON S ROLAN PE POSNER J
Citation: Jd. Davis et al., ATOVAQUONE HAS NO EFFECT ON THE PHARMACOKINETICS OF PHENYTOIN IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 42(2), 1996, pp. 246-248
TUCARESOL INCREASES OXYGEN-AFFINITY AND REDUCES HEMOLYSIS IN SUBJECTSWITH SICKLE-CELL-ANEMIA
Authors: ARYA R ROLAN PE WOOTTON R POSNER J BELLINGHAM AJ
Citation: R. Arya et al., TUCARESOL INCREASES OXYGEN-AFFINITY AND REDUCES HEMOLYSIS IN SUBJECTSWITH SICKLE-CELL-ANEMIA, British Journal of Haematology, 93(4), 1996, pp. 817-821
PHARMACOKINETICS AND PHARMACODYNAMICS OF TUCARESOL, AN ANTISICKLING AGENT, IN HEALTHY-VOLUNTEERS
Authors: ROLAN PE MERCER AJ WOOTTON R POSNER J
Citation: Pe. Rolan et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TUCARESOL, AN ANTISICKLING AGENT, IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 39(4), 1995, pp. 375-380
PLASMA-PROTEIN BINDING DISPLACEMENT INTERACTIONS - WHY ARE THEY STILLREGARDED AS CLINICALLY IMPORTANT
Authors: ROLAN PE
Citation: Pe. Rolan, PLASMA-PROTEIN BINDING DISPLACEMENT INTERACTIONS - WHY ARE THEY STILLREGARDED AS CLINICALLY IMPORTANT, British journal of clinical pharmacology, 37(2), 1994, pp. 125-128
EXAMINATION OF SOME FACTORS RESPONSIBLE FOR A FOOD-INDUCED INCREASE IN ABSORPTION OF ATOVAQUONE
Authors: ROLAN PE MERCER AJ WEATHERLEY BC HOLDICH T MEIRE H PECK RW RIDOUT G POSNER J
Citation: Pe. Rolan et al., EXAMINATION OF SOME FACTORS RESPONSIBLE FOR A FOOD-INDUCED INCREASE IN ABSORPTION OF ATOVAQUONE, British journal of clinical pharmacology, 37(1), 1994, pp. 13-20
Risultati: 1-15 |